The trademark application ADKUDO was filed by Corcept Therapeutics Incorporated, a U.S. corporation (the "Applicant"). The application was published for oppositions on March 9, 2022, and it was registered by office on June 16, 2022 without any oppositions.
The application was filed in English (German was selected as the second language).
Partial Surrender of the trademark registration was recorded on December 14, 2022. Change of name and professional address of the trademark registration was recorded on July 25, 2023.
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceutical preparations for the treatment of endocrine diseases and disorders
Pharmaceutical preparations for the treatment of psychiatric and neurological diseases and disorders
Pharmaceutical preparations for the treatment of Cushing's syndrome and Cushing's disease
Pharmaceutical preparations for the treatment of cancer, liver disorders, oncologic, metabolic, cardiovascular, ophthalmic, and gastroenterologic diseases and disorders
All of the foregoing excluding pharmaceutical preparations administered by infusion or for treating hematological diseases, hematological disorders, or blood cancers.